ArticleAnnals of medicine and surgery (2012)2026
The association between crystallopathy and postoperative complications following total hip and knee arthroplasty: a systematic review and meta-analysis.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Crystallopathies, including gout and calcium pyrophosphate deposition (CPPD), are prevalent conditions that complicate total joint arthroplasty (TJA). This study aims to evaluate the impact of crystallopathy on postoperative outcomes following total hip and knee arthroplasty, including complication rates, revision risks, and functional recovery. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA 2020 guidelines. Studies comparing the outcomes in adult patients undergoing total hip or knee arthroplasty between cases with and without crystallopathy were included. A random-effects meta-analysis was performed using R software version 4.4.2. Sensitivity and subgroup analyses were conducted to identify outliers and assess effect sizes based on crystallopathy type and arthroplasty type. Results: A total of 23 267 319 TJA cases, including 921 787 crystallopathy group cases, were analyzed. The meta-analysis revealed a significantly higher rate of wound complications (OR = 1.41, 95% CI: 1.03-1.91), prosthetic joint infection (PJI) (OR = 1.97, 95% CI: 1.01-3.83), thromboembolic events (OR = 1.19, 95% CI: 1.06-1.33), and non-home discharge rates (OR = 1.20, 95% CI: 1.02-1.40) in the crystallopathy group, all of which lost significance in sensitivity analysis. However, no significant differences were observed in in-hospital mortality, transfusion needs, myocardial infarction (MI), revision surgery, length of stay (LOS), hospital charges, and emergency department (ED) visits. Conclusion: Patients with crystallopathies might be at an increased risk of wound complications, PJI, thromboembolic events, and non-home discharge. These findings emphasize the importance of preoperative risk assessment and personalized perioperative management for this patient group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.